Human iPSC-derived Brain Microvascular Endothelial Cells
Human iPSC-derived Brain Microvascular Endothelial Cells (iBMECs) from Ace Therapeutics are derived from integration-free induced pluripotent stem cell (iPSC) lines under a fully defined proprietary induction condition. iBMEC cells are compact cellular structures when plated as a monolayer in culture and express standard biomarkers such as ECadherin and ZO-1 using immunohistochemistry methods and transporter biomarkers such as ABCB1 (P-gp), ABCG2, ABCE1, HIF1A, CLDN5, GLUT1, LAT1, MCT1, TJP1, PDGFbeta, OCLN, SLC25A3, TFR1, and SLC25A5 using RT/qPCR methods. Each vial contains at least 1×10^6 cells per ml and is delivered frozen.
Supplier | Ace Therapeutics |
---|---|
Product # | BBM-C-166 |
Pricing | Inquiry |
Product Category | Stem Cells |
Species | Human |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Recommended Medium | It is recommended to use Human iPSC-derived Brain Microvascular Endothelial Cells Medium Kit for culturing in vitro. |
Cell Type | Stem Cell |
Disease | Normal |
Quality Control | Human iPSC-derived Brain Microvascular Endothelial Cells test negative for bacteria, yeast, fungi, and mycoplasma. |
Shipping and Storage |
|